Searched for
RAJIV MALIK
H-1B workers get relief as US court scraps $100,000 fee; employers may accelerate filingsA US federal judge struck down the $100,000 fee for fresh H-1B petitions, deeming it an unlawful tax. This ruling could encourage more appl...- When the dissident is a patriot: New Mammootty-Mohanlal double-engine film is brave for our hyper-ventilating timesMammootty and Mohanlal star in Patriot, a Malayalam film exploring surveillance and privacy. The movie bravely addresses these global issue...
- Viatris president Rajiv Malik to retire in April next yearMalik was instrumental in the $12 billion merger of Mylan with Pfizer's generic drug unit that resulted in the creation of Viatris in 2019....
- Bofors petitioner and former BJP leader campaigns against Modi in VaranasiAgarwal, a senior lawyer, said that no charge was ever proven in any court of the country against former Prime Minister Rajiv Gandhi in the...
- Ayushman plan brilliant move; India needed it, says Rajiv Malik, President, MylanThe Nasdaq-listed company will work with the government to expand affordable healthcare for infectious diseases like HIV and tuberculosis, ...
- Biocon-Mylan win US nod for another biosimilar drugBiosimilars are emerging as the new class of affordable drugs.
- Deepa Malik to receive MG Mehta Human Spirit awardThe Rio Paralympics silver medalist was honoured with the Padma Shri earlier this year and Arjuna Award in 2012.
- USFDA accepts Mylan's BLA for proposed biosimilar PegfilgrastimThe proposed biosimilar Pegfilgrastim is one of the six biologic products co-developed by Mylan and Biocon for the global marketplace, the ...
- US FDA accepts Biocon-Mylan biosimilar application for proposed anti-cancer bio-similarBiocon said that the FDA's acceptance for review of this biosimilar is an outcome of the company’s strong R&D and manufacturing capabilitie...
- USFDA accepts Mylan's application for proposed biosimilar TrastuzumabThis is Mylan and Biocon's "first US regulatory submission through the 351(k) pathway and reinforces the strength of collaboration."
- Sakshi Malik all set to get Khel Ratna for her Olympic medalIt has been decided that during Olympic years anyone, who wins a medal, will be automatically conferred with the Rajiv Gandhi Khel Ratna aw...
- India makes all Mylan HIV drugs for developing world: Rajiv Malik, President, MylanWe were second to enter the US in the marketing of a generic version of AstraZeneca's heartburn drug Nexium, but we still managed to build ...
- We're here to stay, open to buy right portfolio: Rajiv Malik, President, MylanMylan is committed to staying in India and plans to build up its presence gradually while remaining open to acquisition, says Rajiv Malik.
- Mylan launches hepatitis-C Sovaldi tablets in IndiaSovaldi is sold by Mylan's dedicated sales force as part of its Hepato Care segment.
- Gap may partner Arvind for India entry next yearGap will join global fashion apparel brands such as Zara, Mango and Marks & Spencer, among others, that already have presence in India.
- US garment retailer Gap set to enter India early next yearGap has almost sealed the deal with Ahmedabad-based textile conglomerate Arvind Ltd to open its branded stores in India, according to a sou...
- Government, political parties slam Malik for Shah Rukh Khan's security demand"We are capable of looking after our own citizens, let him worry about the security of his country's citizens," said Union Home Secretary R...
- BJP attacks government on Rehman Malik's statement over Babri MasjidBJP today sought to corner the government over the controversial statement by Rehman Malik equating Babri Masjid demolition.
- Priyanka's children remind people in Amethi of Rajiv Gandhi eraPriyanka Gandhi's children in electioneering revived among old Congress supporters memories of days when her father used to bring his famil...
- Sacrifice in growth needed to curb inflation: Rajiv Malik, CLSAIndia's monthly industrial production data is like trying to make sense out of senseless volatility. It is a national embarrassment.
Load More
